Global Crypto Card Payment Volume Hits $1.5B Monthly
“`html
The Inflation Reduction Act of 2022
Table of Contents
The inflation Reduction Act of 2022 is a landmark United States federal law enacted on August 16, 2022, primarily focused on reducing healthcare costs, addressing climate change, and increasing tax revenue.
Signed into law by President Joe Biden, the act represents a significant investment in clean energy and climate resilience, aiming to lower carbon emissions by roughly 40% by 2030. It also allows Medicare to negotiate prescription drug prices, a long-sought goal of Democrats, and extends Affordable Care Act subsidies. Funding for these provisions comes largely from a 15% corporate minimum tax on companies with over $1 billion in profits and increased IRS tax enforcement.
On December 29,2022,the Biden-Harris Management announced that the Inflation reduction Act was already lowering costs for American families, investing in America, and fighting climate change.
Key Provisions: Climate Change & Energy
The Inflation Reduction Act allocates approximately $369 billion towards climate and energy programs, making it the largest climate investment in U.S. history.
These investments include tax credits for renewable energy production, electric vehicle purchases, and energy efficiency improvements. The Act also establishes grant programs to support clean energy technologies and infrastructure development. A key component is the extension and expansion of the Investment Tax Credit (ITC) and Production Tax Credit (PTC) for renewable energy projects.
For example, the Act provides a tax credit of up to $7,500 for the purchase of a new electric vehicle, as detailed in the IRS guidance released in April 2023. These credits are subject to certain income and vehicle price limitations.
Healthcare Cost Reduction
A central aim of the Inflation Reduction Act is to lower healthcare costs, particularly prescription drug prices.
The act authorizes Medicare to negotiate the prices of certain high-cost prescription drugs, starting with 10 drugs in 2026, increasing to 20 drugs by 2029. This negotiation power is expected to save Medicare and beneficiaries billions of dollars. Additionally, the Act extends enhanced Affordable Care Act (ACA) subsidies through 2025, preventing premium increases for millions of Americans.
The congressional Budget Office estimated that allowing Medicare to negotiate drug prices woudl save the federal government $101.4 billion over ten years (2022-2031).
Tax Provisions & Revenue
The Inflation Reduction Act introduces several tax provisions designed to raise revenue and offset the costs of its spending programs.
The most significant is a 15% minimum tax on corporations with average annual profits exceeding $1 billion, as outlined in Treasury Department documentation. The act also increases funding for the Internal revenue service (IRS) to improve tax enforcement and compliance. These measures are projected to generate hundreds of billions of dollars in revenue over the next decade.
According to the Joint Committee on Taxation, the corporate minimum tax is expected to raise approximately $220 billion over ten years.
Legal Challenges and Current Status (as of January 18, 2026)
The Inflation Reduction Act has faced several legal challenges, primarily concerning the constitutionality of its corporate minimum tax and the structure of its tax credits.
As of January 18, 2026, the Supreme Court ruled (in *Liberty Energy And Hydraulic Services, LLC v. United States*)